ALX Oncology's shares surge after venture capital firm venBio's significant purchase.

miércoles, 4 de febrero de 2026, 5:43 pm ET1 min de lectura
ALXO--

ALX Oncology (ALXO) shares rose around 10% in after-hours trading on Wednesday after a venture capital firm, venBio Capital, purchased nearly 3.2 million shares at $1.57 each. The purchase was made on February 2, with a total value not disclosed.

ALX Oncology's shares surge after venture capital firm venBio's significant purchase.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios